The present invention provides methods for characterization of atherosclerotic plaque by measurement of tissue optical properties, such as by optical coherence tomography.
Myocardial infarction is the major cause of death in industrialized countries. Rupture of vulnerable atherosclerotic plaques is currently recognized as an important mechanism for acute myocardial infarction, which often results in sudden death. Recent advances in cardiovascular research have identified anatomic, biomechanical, and molecular features of atherosclerotic plaques that predispose them to rupture. In a majority of vulnerable plaques, these features include 1) the presence of activated macrophages at the shoulder or edge of the plaque, 2) a thin fibrous cap (<60 μm) and 3) a large lipid pool. The lipid pool is thought to apply force to the fibrous cap that causes it to become compromised. Once it is ruptured, the lipid enters the vessel lumen, causing thrombosis, arterial occlusion, myocardial ischemia, and infarction. In addition to lipid-rich plaques with a thin fibrous cap, other plaque types have been recently implicated as vulnerable plaques. These plaques contain a surface erosion where the intima has been denuded, leaving a rough surface at risk for causing platelet aggregation and acute thrombosis.
Coronary arteries that do not contain plaque have a layered structure consisting of an intima, media, and adventitia. A simple model of a lipid-rich plaque is a two layered structure consisting of a fibrous cap and an underlying lipid pool. Other atherosclerotic plaque types consist of one layer, either fibrous or calcified. Research indicates that the distinct layers present in atherosclerotic plaques have different scattering, absorption, and anisotropy coefficients. It is believed that the measurement of these parameters using light will enable characterization of plaque type in vivo and allow for the diagnosis of vulnerable plaques.
Cellularity of fibrous caps of atherosclerotic plaque, manifested by the infiltration of macrophages (average size 20-50 μm), is thought to weaken the structural integrity of the cap and predispose plaques to rupture. Macrophages, and other plaque related cells, produce proteolytic enzymes such as matrix metalloproteinases that digest extracellular matrix and compromise the integrity of the fibrous cap. Activated macrophages are strongly colocalized with local thrombi in patients who have died of acute myocardial infarction and are more frequently demonstrated in coronary artery specimens obtained from patients suffering from acute coronary syndromes compared with patients with stable angina. This evidence suggests that an imaging technology capable of identifying macrophages in patients would provide valuable information for assessing the likelihood of plaque rupture. Results from intracoronary OCT, recently performed in patients, have shown an improved capability for characterizing plaque microstructure compared with IVUS. To date, however, the use of OCT for characterizing the cellular constituents of fibrous caps has not been fully investigated.
It would be desirable to have a means for using remitted light to measure the optical properties of atherosclerotic plaques, determine plaque cap thickness or identify plaques with surface erosions and as a result assess coronary plaque vulnerability.
A method that detects plaques vulnerable to rupture could become a valuable tool for guiding management of patients at risk and may ultimately prevent acute events. Many different catheter-based methods are under investigation for the detection of vulnerable plaques. These methods include intravascular ultrasound (IVUS), optical coherence tomography (OCT), fluorescence spectroscopy, and infrared spectroscopy. While IVUS and OCT are used to obtain cross-sectional images of tissue, only OCT has been shown to have sufficient resolution to detect the presence of a thin fibrous cap. Fluorescence and infrared spectroscopy are methods that primarily detect the presence of lipids within the vessel wall. Of the four proposed techniques, only OCT has been shown to be capable of spatially resolving parameters directly responsible for plaque rupture.
Background Principles
The backreflected light scattered from within a turbid medium, such as tissue, is affected by the optical properties of the medium. The optical properties that determine the propagation of light in tissue are the absorption coefficient, μa, the scattering coefficient, μs and the total attenuation coefficient, μt, where
μtμs+μa
The absorption coefficient is linearly related to the concentration of the absorber, such that
μa=ε[Ab]
where ε is the molar extinction coefficient for the absorber and [Ab] is the molar concentration of the absorber.
Often, the mean cosine of the scattering phase function, g, is combined with μs to form the transport scattering coefficient:
μ′s=μs(1−g)
Propagation of light described using the transport scattering coefficient can be considered isotropic since the scattering coefficient has been normalized by the anisotropy coefficient, g.
Propagation of light within multiply scattering media is described by the radiative transport equation. Solutions to the radiative transport equation by use of diffusion theory approximations have allowed the use of remitted light to predict the optical properties of homogeneous highly scattering media. Application of these techniques for diagnosing neoplasia has been problematic, however, due to tissue inhomogeneities and the large depth of tissue which must be probed to identify small tumors deeply embedded in tissue. Nevertheless, in the limited setting of atherosclerotic plaques, the tissue structure is less heterogeneous and the pathology is at the surface of the vessel. These two features of arterial pathology make characterization of atherosclerotic plaques by measurement of optical properties possible.
The present invention describes methods for determining the fibrous cap thickness and measuring tissue optical properties. In one embodiment of the present invention, the presence of a large lipid pool underlying the cap is measured. In another embodiment, macrophage degradation can be identified. Moreover, use of these techniques may allow determination of plaques containing surface erosions.
Several methods for measuring the optical properties of tissue can potentially be used to investigate the structure of atherosclerotic plaques. Some of the methods described below may be modified, as is known to those skilled in the art, to incorporate multiple layers. These techniques may also be used as stand-alone measurements, or in combination.
Spatially Dependent Reflectance Measurements
A single spot on the sample is irradiated with single or multiple wavelengths of light. The remitted light as a function of distance from the sample, r, is measured. Using the diffusion approximation and/or Monte Carlo simulation results, this radial remittance profile, combined with the total reflectance from the sample can yield the absorption and transport scattering coefficients of a homogenous medium. Recently, diffusion theory has been used to calculate the optical properties of a two-layered media, and determine the layer thicknesses. In addition to the tissue optical properties, the cap thickness affects this spatial remittance distribution (
Multiple Wavelength Reflectance Measurements
Reflectance measurements may be made using two wavelengths with different penetration depths. If absorption for the two wavelengths is similar in atherosclerotic plaques, then the ratio of the reflectances for the two wavelengths gives an estimate of cap thickness.
Low-Coherence Interferometry (LCI)
Coherence ranging in tissue has been shown to be a powerful method for calculating the optical properties of layered tissue. Multiple linear fits of the LCI axial reflectivity allows determination of the total attenuation coefficient for each layer. Transitions between different linear fits determines the layer thicknesses of the tissue.
Quantification of Macrophage Content
The present invention provides methods for quantification of macrophage content of the cap. High macrophage content is indicative of potential plaque rupture. Several algorithms are presented for determining macrophage density, including, focus tracking, correction of focus, intensity normalization, computation of macrophage density within ROI, and cluster analysis or threshold application. OCT measures the intensity of light returning from within a sample. Samples having a higher heterogeneity of optical index of refraction exhibit stronger optical scattering and therefore a stronger OCT signal. If the characteristic size scale of the index of refraction heterogeneity is larger than the resolution, then the OCT signal will have a larger variance. Previous research conducted to measure the optical properties of human tissue has shown that the refractive index of lipid and collagen is significantly different. Caps containing macrophages should have multiple strong backreflections, resulting in a relatively high OCT signal variance.
A common theme to most of the methods described herein includes the use of a single fiber to irradiate the sample and multiple (small number) of fibers for detection. One embodiment of a catheter capable of making these measurements comprises a fiber optic array (one- or two-dimensional), lens, and prism which is contained within an inner housing capable of rotation. Light from one fiber input is focused by a lens, reflected off of a prism, and directed onto the artery wall. Light reflected from the sample may be collected by other fibers in the fiber bundle. An image of the optical properties may be obtained by rotating the inner housing. Since these techniques can be implemented using fiber optics, these measurements can be made using an intravascular device.
The various features and advantages of the invention will be apparent from the attached drawings, in which like reference characters designate the same or similar parts throughout the figures, and in which:
Spatially Dependent Reflectance
There have been prior attempts to measure the optical properties of human atheromas, but these studies suffer from a number of deficiencies and inaccuracies. In addition, the unique optical properties of atherosclerotic caps and lipid pools have not been independently measured.
Table 1 shows the optical properties of the cap and lipid pool (literature and unpublished research) used for Monte Carlo simulations at 633 nm and 476 nm.
Multiple wavelengths may be used to improve the accuracy of this technique. Spatial reflectance measurements may be obtained for a sufficient number of wavelengths to solve for the multiple degrees of freedom present in the N-layered model. Variables that need to be determined to accurately determine the cap thickness include the absorption coefficient, the transport scattering coefficients for each layer and the layer thickness.
One method according to the present invention for measurement of plaque optical properties and cap thickness is as follows:
FIG. 4A(i) shows a graph of a short temporal pulse going in and
One can also combine spatial frequency and spatial time and/or modulated phase and amplitude measurements.
Multiple Wavelength Reflectance Measurements
The use of the differential penetration depth of light within the fibrous cap provides a simple method for estimating cap thickness. This technique may be performed using a single point measurement or for multiple points as a spatially dependent reflectance profile (as mentioned above). The principle behind this method is illustrated by the following aspects:
There are multiple different wavelength ratiometric equations, including, but not limited to:
R=Iλ1/Iλ2 (1)
R=(Iλ1−Iλ2)/(Iλ1+Iλ2) (2)
R=Iλ1/(Iλ1+Iλ2) (3)
R=(Iλ1−Iλ2)/Iλ2 (4)
The appropriateness of the equation depends on whether or not the total reflectance needs to be accounted for (normalized) to correct for intrapatient and interpatient variation of the cap and lipid pool optical properties.
Low Coherence Interferometry
Low coherence interferometric imaging or optical coherence tomography is a non-invasive cross-sectional imaging technique capable of providing high-resolution images of optical backscattering within tissue. OCT is currently being developed as a commercial product and will likely begin wide-scale clinical trials in the coming years. Current OCT systems have a resolution of 10 μm. Although this resolution allows for imaging of tissue architectural morphology, cellular features are not directly resolved by OCT. As a result, quantitative/qualitative algorithms must be used to correlate architectural features visualized by OCT to identify coronary atherosclerotic plaque type.
Interpretation of OCT images is based on several hypotheses that are directly supported by clinical experience:
1. OCT signal strength increases with nuclear (N) density
2. OCT signal strength increases with fibrous tissue density
3. Lipid exhibits a low OCT signal
4. Calcifium may exhibit a low or high (or alternating low and high) OCT signal
5. The refractive indices of fibrous tissue, lipid, and calcium are distinct. As a result, for well-delineated structures, a high OCT signal (Fresnel reflection) may be observed at the interface between different tissue types.
An algorithm for feature extraction from OCT images is described below. Final diagnosis of coronary pathology can be determined using a grading scheme incorporating some or all of the parameters described herein.
Qualitative Features
Table 2 describes the OCT qualitative features corresponding to histologic finding. Table 2 partially overlaps with published data. However, many OCT features described in Table 2 have not been mentioned in the literature.
We have also recently noted two types of lipid pools, homogeneous and heterogeneous. Homogeneous lipid pools have a greatly decreased signal and contain a Fresnel reflection at the interface. Heterogeneous lipid pools have increased signal compared to homogeneous lipid pools and do not have a visible Fresnel reflection.
Quantitative Features
While many cross-sectional OCT images of human coronary arteries can be readily characterized using simple, qualitative features, heterogeneous plaques with complex components are difficult to interpret. In these cases, the appearance of lipid-rich plaques with thin fibrous caps was similar to that of fibrous plaques with calcifications. To date, few investigators have used advanced image processing algorithms for OCT. Preliminary studies suggest that substantial improvements can be made in identifying tissue constituents through systematic analysis of the two-dimensional OCT signal and that algorithms can be developed for applying this information for contrast enhancement and segmentation.
In current OCT systems, the intensity of light returning from discrete locations within the sample comprises the image data set. The signal detected from any one location is determined by both the attenuation incurred along the optical path between the catheter and the location and the actual reflectivity at that location, R(z):
I(z)=I0R(z)e−μ
where I0 is the incident light intensity, μt is the total attenuation coefficient and z is the distance along the optical axis. As light propagates within tissue it is attenuated by scattering and absorption. In a homogeneous medium, the total attenuation coefficient is independent of depth resulting in a single-exponential decay of signal with depth. In more complex structures the spatial dependence of the attenuation coefficient gives rise to an exponential decay curve with locally varying slope.
Recent work in our laboratory has shown that OCT data representing different components of plaques have distinct local intensity distributions. This realization has motivated the use of three methods for quantitative analysis and segmentation of OCT data representing different tissue types. Computation of the histograms or probability distribution functions (PDF) for different tissue regions has shown that each tissue type has a distinct PDF (
ln [I(z)]=ln [I0]+ln [R(z)]−2μt(z)z Eq. 2
the exponential decay becomes a change in slope, −2μt(z), which is also known as the depth dependent total attenuation coefficient. In a preliminary study, we have measured μt(z), and have found that it is different for calcifications, fibrous caps, and lipid pools.
The present invention provides an algorithm for calculating μt(z) for each point in the image using adaptive linear regression to create new images that represent corrected total attenuation coefficients and corrected reflection coefficients that will provide improved characterization of tissue constituents. The algorithm is as follows:
Polarization sensitive optical coherence tomography is capable of improving the characterization of the composition of atherosclerotic plaques. With this device, quantitative high-resolution depth-resolved detection of plaque birefringence (polarization rotation by the tissue) gives rise to additional information related to plaque composition.
A polarization independent OCT image may be obtained by summing the squares of the magnitude of the interference detected at detectors A and B. If the polarization eigenstates of the electric field incident on the sample are known, then the birefringence of the sample may be computed using a combination of the signals detected by A and B. This is termed polarization sensitive detection. One quantitative measurement of the relative degree of birefringence caused by the sample is:
φ(r,θ)=arctan(A(r,θ)/B(r,θ)) Eq. 3
By analyzing the birefringence, additional information can be obtained from the OCT signal.
In the polarization independent image (
Collagen content is the major intrinsic factor contributing to the stability of a plaque. As a result, a method for measuring the collagen content and its structural orientation will provide additional diagnostic information for differentiating stable from unstable plaques. Also, since an increase in plaque collagen content has been recognized as one of the most important structural changes that occurs following lipid-lowering therapy, measurement of the collagen content with this technique could enable monitoring of plaque regression after pharmacological therapy. In addition, the polarization sensitive OCT signal may improve the capability of OCT to differentiate lipid from fibrous tissue and fibrous tissue from calcium. Finally, other constituents commonly found in atherosclerotic plaques, such as cholesterol crystals, may have a unique polarization sensitive OCT signal.
Macrophage Measurement
Example 1 discussed hereinbelow provides a method and an algorithm for identifying macrophages in fibrous caps.
This example was a project to explore the potential of OCT for identifying macrophages in fibrous caps of atherosclerotic plaques.
Specimens
264 grossly atherosclerotic arterial segments (165 aortas, 99 carotid bulbs) were obtained from 59 patients (32 male and 27 female, mean age 74.2±13.4 years) at autopsy and examined. 71 of these patients had a medical history of symptomatic cardiovascular disease (27.1%). The harvested arteries were stored immediately in phosphate buffered saline at 4 C.°. The time between death and OCT imaging did not exceed 72 hours.
OCT Imaging Studies
The OCT system used in this Example has been previously described. OCT images were acquired at 4 frames per second (500 angular pixels×250 radial pixels), displayed with an inverse gray-scale lookup table, and digitally archived. The optical source used in this experiment had a center wavelength of 1310 nm and a bandwidth of 70 nm, providing an axial resolution of approximately 10 μm in tissue. The transverse resolution, determined by the spot size of the sample arm beam, was 25 μm.
Before OCT imaging, arteries were warmed to 37° C. in phosphate buffered saline. Each carotid bulb and aorta was opened and imaged with the luminal surface exposed. The position of the interrogating beam on the tissue was monitored by a visible light aiming beam (laser diode, 635 nm) that was coincident with the infrared beam. Precise registration of OCT and histology was accomplished by applying ink marks (Triangle Biomedical Sciences, Durham, N.C.) to the vessels at the imaging site, such that each OCT image and corresponding histologic section contained visually recognizable reference points.
Staining
After imaging, the tissue was processed in a routine fashion. Arterial segments were fixed in 10% Formalin (Fisher Scientific, Fair Lawn, N.J.) for at least 48 hours. Arteries with substantial calcification were decalcified (Cal-EX, Fisher Scientific) prior to standard paraffin embedding. Four-micron sections were cut at the marked imaging sites and stained with hematoxylin and eosin (H&E) and Masson's trichrome. To visualize the presence of macrophages and smooth muscle cells, a mouse-antihuman CD68 monoclonal antibody and alpha-actin monoclonal antibody (Dako Corporation, Carpinteria, USA) were used, respectively. Immunohistochemical detection of the preferred epitopes was performed according to the indirect horseradish peroxidase technique. After blocking with horse serum, the tissue was incubated with primary antibodies followed by horse anti-mouse secondary antibody and streptavidin with peroxidase (BioGenex) for anti-smooth muscle actin or avidin-biotin horseradish peroxidase complex (Dako) for anti-CD68. Slides were developed with 3-amino-9-ethyl-carbazole (Sigma) and counterstained with Gill's hematoxylin (Fisher Scientific). All slides were digitized for histomorphometric analysis (Insight Camera, Diagnostic Instruments, Sterling Heights, Mich.).
Correlation between OCT Images and Histopathology
264 OCT images and correlating histologic sections were obtained using the ink marks as points of reference. From this set, 26 plaques identified as fibroatheromas by histology with precise registration between OCT and histology as determined by reference ink marks and minimal superficial calcification by histology, were selected to correlate measurements of macrophage density.
Morphometric Analysis
Using both digitized histology and OCT, measurements of macrophage density were obtained using a 500×125 μm (lateral×axial) region of interest (ROI), located in the center of the plaque (
OCT measures the intensity of light returning from within a sample. Samples having a higher heterogeneity of optical index of refraction exhibit stronger optical scattering and therefore a stronger OCT signal. If the characteristic size scale of the index of refraction heterogeneity is larger than the resolution, then the OCT signal will have a larger variance. Previous research conducted to measure the optical properties of human tissue has shown that the refractive index of lipid and collagen is significantly different. These results suggest that caps containing macrophages should have multiple strong backreflections, resulting in a relatively high OCT signal variance. Using standard image processing methods, the variance, σ2, within the ROI of an OCT image can be represented by:
where N is the number of pixels in the ROI, ROIwidth is the width of the ROI, ROIheight is the height of the ROI, S(x,y) is the OCT signal as a function of x and y locations within the ROI, and
OCT images contain tissue backreflection information that span a large dynamic range (100 dB or 10 orders of magnitude). The dynamic range of OCT is too high to be displayed on a standard monitor that may have a dynamic range of only 2-3 orders of magnitude. As a result, the signal range of most OCT images are compressed by taking the base 10 logarithm of the OCT image prior to display. While taking the logarithm of the OCT image data enables convenient image display, compression of the data range in this manner diminishes image contrast. In this study, we investigated the capabilities of both the raw (linear) OCT data and the logarithm of the OCT data for quantifying macrophage content within fibrous caps.
Prior to computing the image standard deviation, the OCT data within the ROI was preprocessed using the following steps: 1) the mean background noise level was subtracted, and 2) median filtering using a 3×3 square kernel was performed in order to remove speckle noise (IPLab Spectrum 3.1, Scanalytics, Vienna, Va.). Following preprocessing, or within the ROI was calculated and tabulated for each specimen. In order to correct the data for variations in OCT system settings, σ was normalized by the maximum and minimum OCT signal present in the OCT image:
where NSD is the normalized standard deviation of the OCT signal, Smax is the maximum OCT image value, and Smin is the minimum OCT image value.
The area percentage of CD68+ and smooth muscle actin staining was quantified (at 100× magnification) using automatic bimodal color segmentation within the corresponding ROI's of the digitized Immunohistochemical stained slides (IPLab Spectrum 3.1, Scanalytics, Vienna, Va.). The NSD within each cap was then compared with immunohistochemical staining from slides obtained from corresponding locations.
Statistics
OCT measurements of macrophage and smooth muscle density were compared to histologic measurements using linear regression. In addition, following retrospective application of an NSD threshold, the accuracy of OCT for identifying caps with >10% CD68+ staining was determined. All continuous variables are expressed as mean±standard deviation. A p value <0.05 was considered statistically significant.
Results
Macrophage Density
The OCT signal within the cap is relatively homogeneous for low macrophage density, whereas for high macrophage content, the OCT image of the cap is heterogeneous with punctate, highly reflecting regions. The relationship between macrophage density determined by immunohistochemistry and the NSD measured by OCT is depicted in
Morphometric evaluation of 26 slides stained with CD68 showed 9 caps with a CD68+ area greater than 10% and 17 caps with a CD68+ area less than 10%. Receiver operating characteristic (ROC) curves for the raw and base 10 logarithm OCT signal NSD's are depicted in
Smooth Muscle Cell Density
A negative correlation was found between CD68 and smooth muscle actin % area staining (r=−0.44, p<0.05). In turn, a statistically significant negative relationship between smooth muscle cell density determined by immunohistochemistry and OCT NSD was observed for both the raw and base 10 logarithm OCT data. For the raw OCT data, a correlation of r=−0.56 (p<0.005) was found between OCT NSD and smooth muscle actin+% staining, whereas for the base 10 logarithm OCT data, a correlation of r=−0.32 (p=0.12) was found between OCT NSD and smooth muscle actin+% staining.
Other Findings
Macrophages at the cap-lipid pool interface: CD68 staining demonstrated a significant accumulation of macrophages at the cap-lipid pool interface in (n=19) cases. In 16 of these cases (84%), a higher OCT signal was also present at the junction between the cap and the lipid pool, confirming that the increase in OCT signal was in part due to increased backreflection by macrophages at the cap-lipid pool interface. For the three CD68+ cases lacking an increase in OCT signal at the junction, either the cap was greater than 300 μm in thickness or the entire cap was infiltrated by macrophages. In the three cases that were negative for CD68 at the cap-lipid pool interface, an increased OCT interface signal corresponded to cholesterol crystals present at the junction.
Although many new approaches under investigation for plaque characterization show great promise, none provide direct evidence of macrophage presence. This Example demonstrates that OCT is capable of visualizing macrophages and quantifying cap macrophage content. Since the OCT signal increases with the number of refractive index mismatches in tissue, caps containing macrophages should have multiple strong backreflections. A simple computational analysis of ROI's within OCT images of fibrous caps (NSD) was developed to test this hypothesis. When validated against immunohistochemistry, this parameter demonstrated a high degree of correlation with CD68 staining at corresponding locations (r=0.84 for raw OCT data NSD).
While little is known about the precise relationship between cap macrophage density and plaque vulnerability, studies have shown that plaques with a macrophage content in the range of 10%-20% are more likely to be associated with unstable angina and non-Q wave myocardial infarction6. As a result, we selected 10% CD68+ area as a cutoff for high macrophage content. Using the ROC to select an appropriate NSD threshold, we found that OCT was capable of accurately distinguishing fibrous caps with low macrophage content from fibrous caps with high macrophage content (100% sensitivity and specificity for raw OCT data NSD).
An increased number of smooth muscle cells have been observed within plaques in patients who have unstable angina and within erosive plaques implicated in a subset of acute myocardial infarctions. In this work, we found an inverse correlation between CD68 and smooth muscle actin staining from corresponding locations within plaque caps (r=−0.44, p<0.05). The negative correlation between the raw OCT data NSD and smooth muscle actin staining (r=−0.56, p<0.005) may in part reflect the inverse relationship between macrophages and smooth muscle cells in our data. Nevertheless, it appears that the OCT NSD is specific for macrophage content, as opposed to being a more general metric of increased cellular density.
In this Example, both the raw OCT signal and the logarithm of the OCT signal was processed and compared with CD68 immunohistochemical positivity. While the logarithm of the OCT signal provides an increased dynamic range for image display, it also apparently decreases the contrast between macrophages and surrounding matrix (Table 3).
Alternative Methods for Identifying Inflammation in Atherosclerotic Plaques
Diffuse near-infrared (NIR) reflectance spectroscopy is a quantitative approach that utilizes the spectrum of light scattered from within the vessel wall. A recent study, performed on cadaver specimens, has demonstrated that chemometric analysis of the NIR spectrum may allow identification of plaques containing abundant inflammatory cells. Based on the hypothesis that local inflammation within vulnerable plaques may lead to local elevations in temperature, studies have recently been performed using a temperature-sensing catheter. Experiments performed in patients have indicated that both temperature heterogeneity and the temperature difference between atherosclerotic plaque and healthy vessel walls increase with disease severity. Both NIR spectroscopy and thermography appear quite promising for assessing inflammation within plaques, but these diagnostic techniques are not specific for macrophages and may need to be combined with another imaging modality to precisely determine whether or not the inflammatory cells are confined to the fibrous cap, or are present throughout the plaque. Recently, ultrasmall superparamagnetic particles of iron oxide (USPIOs) have been proposed for delineation of inflammatory changes accompanying atherosclerotic disease. The limited resolution of MRI, however, renders the localization of macrophages within thin fibrous cap and plaque shoulders difficult.
Alternative Algorithms and Methods:
In addition to the algorithm described hereinabove in Example 1, the following alternative embodiments for determining macrophage content could also be employed:
Any combination of the techniques described below could be used in an algorithm for determining macrophage density
Focus Tracking
Precise knowledge of the position of the focus of the imaging lens may be needed for accurate quantification. This may be accomplished by determining the maximum axial OCT signal or by a priori knowledge of the position of the focus on the OCT image.
Correction of Focus
The OCT image may be corrected to form a map of the true backscattering coefficient by an adaptive correction for the attenuation coefficient and extrapolation using 1×n kernels in the OCT image. The resultant image would be a map of the true backscattering coefficients, corrected for attenuation.
Intensity Normalization
Cluster analysis or threshold application may be needed to separate out plaques or ROI's with high macrophage content versus low macrophage content.
It will be understood that the terms “a” and “an” as used herein are not intended to mean only “one,” but may also mean a number greater than “one.” All patents, applications and publications referred to herein are hereby incorporated by reference in their entirety. While the invention has been described in connection with certain embodiments, it is not intended to limit the scope of the invention to the particular forms set forth, but, on the contrary, it is intended to cover such alternatives, modifications, and equivalents as may be included within the true spirit and scope of the invention as defined by the appended claims.
The present application is a divisional of U.S. patent application Ser. No. 10/137,749, filed May 1, 2002 now U.S. Pat. No. 7,865,231. This application also claims priority from provisional application No. 60/287,899, filed May 1, 2001, and commonly assigned to the assignee of the present application. The disclosures of these applications are incorporated herein by reference in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
2339754 | Brace | Jan 1944 | A |
3090753 | Matuszak et al. | May 1963 | A |
3601480 | Randall | Aug 1971 | A |
3856000 | Chikama | Dec 1974 | A |
3872407 | Hughes | Mar 1975 | A |
3941121 | Olinger | Mar 1976 | A |
3973219 | Tang et al. | Aug 1976 | A |
3983507 | Tang et al. | Sep 1976 | A |
4030827 | Delhaye et al. | Jun 1977 | A |
4030831 | Gowrinathan | Jun 1977 | A |
4140364 | Yamashita et al. | Feb 1979 | A |
4141362 | Wurster | Feb 1979 | A |
4224929 | Furihata | Sep 1980 | A |
4295738 | Meltz et al. | Oct 1981 | A |
4300816 | Snitzer et al. | Nov 1981 | A |
4303300 | Pressiat et al. | Dec 1981 | A |
4428643 | Kay | Jan 1984 | A |
4479499 | Alfano | Oct 1984 | A |
4533247 | Epworth | Aug 1985 | A |
4585349 | Gross et al. | Apr 1986 | A |
4601036 | Faxvog et al. | Jul 1986 | A |
4607622 | Fritch et al. | Aug 1986 | A |
4631498 | Cutler | Dec 1986 | A |
4639999 | Daniele | Feb 1987 | A |
4650327 | Ogi | Mar 1987 | A |
4734578 | Horikawa | Mar 1988 | A |
4744656 | Moran et al. | May 1988 | A |
4751706 | Rohde et al. | Jun 1988 | A |
4763977 | Kawasaki et al. | Aug 1988 | A |
4770492 | Levin et al. | Sep 1988 | A |
4827907 | Tashiro et al. | May 1989 | A |
4834111 | Khanna et al. | May 1989 | A |
4868834 | Fox et al. | Sep 1989 | A |
4890901 | Cross, Jr. | Jan 1990 | A |
4892406 | Waters | Jan 1990 | A |
4905169 | Buican et al. | Feb 1990 | A |
4909631 | Tan et al. | Mar 1990 | A |
4925302 | Cutler | May 1990 | A |
4928005 | Lefèvre et al. | May 1990 | A |
4940328 | Hartman | Jul 1990 | A |
4965441 | Picard | Oct 1990 | A |
4965599 | Roddy et al. | Oct 1990 | A |
4966589 | Kaufman | Oct 1990 | A |
4984888 | Tobias et al. | Jan 1991 | A |
4993834 | Carlhoff et al. | Feb 1991 | A |
4998972 | Chin et al. | Mar 1991 | A |
5039193 | Snow et al. | Aug 1991 | A |
5040889 | Keane | Aug 1991 | A |
5045936 | Lobb et al. | Sep 1991 | A |
5046501 | Crilly | Sep 1991 | A |
5065331 | Vachon et al. | Nov 1991 | A |
5085496 | Yoshida et al. | Feb 1992 | A |
5120953 | Harris | Jun 1992 | A |
5121983 | Lee | Jun 1992 | A |
5127730 | Brelje et al. | Jul 1992 | A |
5197470 | Helfer et al. | Mar 1993 | A |
5202745 | Sorin et al. | Apr 1993 | A |
5202931 | Bacus et al. | Apr 1993 | A |
5208651 | Buican | May 1993 | A |
5212667 | Tomlinson et al. | May 1993 | A |
5214538 | Lobb | May 1993 | A |
5217456 | Narciso, Jr. | Jun 1993 | A |
5228001 | Birge et al. | Jul 1993 | A |
5241364 | Kimura et al. | Aug 1993 | A |
5248876 | Kerstens et al. | Sep 1993 | A |
5250186 | Dollinger et al. | Oct 1993 | A |
5251009 | Bruno | Oct 1993 | A |
5262644 | Maguire | Nov 1993 | A |
5275594 | Baker | Jan 1994 | A |
5281811 | Lewis | Jan 1994 | A |
5283795 | Fink | Feb 1994 | A |
5291885 | Taniji et al. | Mar 1994 | A |
5293872 | Alfano et al. | Mar 1994 | A |
5293873 | Fang | Mar 1994 | A |
5302025 | Kleinerman | Apr 1994 | A |
5304173 | Kittrell et al. | Apr 1994 | A |
5304810 | Amos | Apr 1994 | A |
5305759 | Kaneko et al. | Apr 1994 | A |
5317389 | Hochberg et al. | May 1994 | A |
5318024 | Kittrell et al. | Jun 1994 | A |
5321501 | Swanson et al. | Jun 1994 | A |
5348003 | Caro | Sep 1994 | A |
5353790 | Jacques et al. | Oct 1994 | A |
5383467 | Auer et al. | Jan 1995 | A |
5394235 | Takeuchi et al. | Feb 1995 | A |
5404415 | Mori et al. | Apr 1995 | A |
5411016 | Kume et al. | May 1995 | A |
5419323 | Kittrell et al. | May 1995 | A |
5424827 | Horwitz et al. | Jun 1995 | A |
5439000 | Gunderson et al. | Aug 1995 | A |
5441053 | Lodder et al. | Aug 1995 | A |
5450203 | Penkethman | Sep 1995 | A |
5454807 | Lennox et al. | Oct 1995 | A |
5459325 | Hueton et al. | Oct 1995 | A |
5459570 | Swanson et al. | Oct 1995 | A |
5465147 | Swanson | Nov 1995 | A |
5486701 | Norton et al. | Jan 1996 | A |
5491524 | Hellmuth et al. | Feb 1996 | A |
5491552 | Kittrell | Feb 1996 | A |
5522004 | Djupsjobacka et al. | May 1996 | A |
5526338 | Hasman et al. | Jun 1996 | A |
5555087 | Miyagawa et al. | Sep 1996 | A |
5562100 | Kittrell et al. | Oct 1996 | A |
5565983 | Barnard et al. | Oct 1996 | A |
5565986 | Knüttel | Oct 1996 | A |
5566267 | Neuberger | Oct 1996 | A |
5583342 | Ichie | Dec 1996 | A |
5590660 | MacAulay et al. | Jan 1997 | A |
5600486 | Gal et al. | Feb 1997 | A |
5601087 | Gunderson et al. | Feb 1997 | A |
5621830 | Lucey et al. | Apr 1997 | A |
5623336 | Raab et al. | Apr 1997 | A |
5635830 | Itoh | Jun 1997 | A |
5649924 | Everett et al. | Jul 1997 | A |
5697373 | Richards-Kortum et al. | Dec 1997 | A |
5698397 | Zarling et al. | Dec 1997 | A |
5710630 | Essenpreis et al. | Jan 1998 | A |
5716324 | Toida | Feb 1998 | A |
5719399 | Alfano et al. | Feb 1998 | A |
5730731 | Mollenauer et al. | Mar 1998 | A |
5735276 | Lemelson | Apr 1998 | A |
5740808 | Panescu et al. | Apr 1998 | A |
5748318 | Maris et al. | May 1998 | A |
5748598 | Swanson et al. | May 1998 | A |
5752518 | McGee et al. | May 1998 | A |
5784352 | Swanson et al. | Jul 1998 | A |
5785651 | Kuhn et al. | Jul 1998 | A |
5795295 | Hellmuth et al. | Aug 1998 | A |
5801826 | Williams | Sep 1998 | A |
5801831 | Sargoytchev et al. | Sep 1998 | A |
5803082 | Stapleton et al. | Sep 1998 | A |
5807261 | Benaron et al. | Sep 1998 | A |
5810719 | Toida | Sep 1998 | A |
5817144 | Gregory | Oct 1998 | A |
5836877 | Zavislan et al. | Nov 1998 | A |
5840023 | Oraevsky et al. | Nov 1998 | A |
5840075 | Mueller et al. | Nov 1998 | A |
5842995 | Mahadevan-Jansen et al. | Dec 1998 | A |
5843000 | Nishioka et al. | Dec 1998 | A |
5843052 | Benja-Athon | Dec 1998 | A |
5847827 | Fercher | Dec 1998 | A |
5862273 | Pelletier | Jan 1999 | A |
5865754 | Sevick-Muraca et al. | Feb 1999 | A |
5867268 | Gelikonov et al. | Feb 1999 | A |
5871449 | Brown | Feb 1999 | A |
5872879 | Hamm | Feb 1999 | A |
5877856 | Fercher | Mar 1999 | A |
5887009 | Mandella et al. | Mar 1999 | A |
5892583 | Li | Apr 1999 | A |
5910839 | Erskine et al. | Jun 1999 | A |
5912764 | Togino | Jun 1999 | A |
5920373 | Bille | Jul 1999 | A |
5920390 | Farahi et al. | Jul 1999 | A |
5921926 | Rolland et al. | Jul 1999 | A |
5926592 | Harris et al. | Jul 1999 | A |
5949929 | Hamm | Sep 1999 | A |
5951482 | Winston et al. | Sep 1999 | A |
5955737 | Hallidy et al. | Sep 1999 | A |
5956355 | Swanson et al. | Sep 1999 | A |
5968064 | Selmon et al. | Oct 1999 | A |
5975697 | Podoleanu et al. | Nov 1999 | A |
5983125 | Alfano et al. | Nov 1999 | A |
5987346 | Benaron et al. | Nov 1999 | A |
5991697 | Nelson et al. | Nov 1999 | A |
5994690 | Kulkarni et al. | Nov 1999 | A |
5995223 | Power | Nov 1999 | A |
6002480 | Izatt et al. | Dec 1999 | A |
6004314 | Wei et al. | Dec 1999 | A |
6006128 | Izatt et al. | Dec 1999 | A |
6007996 | McNamara et al. | Dec 1999 | A |
6010449 | Selmon et al. | Jan 2000 | A |
6014214 | Li | Jan 2000 | A |
6016197 | Krivoshlykov | Jan 2000 | A |
6020963 | Dimarzio et al. | Feb 2000 | A |
6025956 | Nagano et al. | Feb 2000 | A |
6033721 | Nassuphis | Mar 2000 | A |
6037579 | Chan et al. | Mar 2000 | A |
6044288 | Wake et al. | Mar 2000 | A |
6045511 | Ott et al. | Apr 2000 | A |
6048742 | Weyburne et al. | Apr 2000 | A |
6053613 | Wei et al. | Apr 2000 | A |
6069698 | Ozawa et al. | May 2000 | A |
6078047 | Mittleman et al. | Jun 2000 | A |
6091496 | Hill | Jul 2000 | A |
6091984 | Perelman et al. | Jul 2000 | A |
6094274 | Yokoi | Jul 2000 | A |
6107048 | Goldenring et al. | Aug 2000 | A |
6111645 | Tearney et al. | Aug 2000 | A |
6117128 | Gregory | Sep 2000 | A |
6120516 | Selmon et al. | Sep 2000 | A |
6134003 | Tearney et al. | Oct 2000 | A |
6134010 | Zavislan | Oct 2000 | A |
6134033 | Bergano et al. | Oct 2000 | A |
6141577 | Rolland et al. | Oct 2000 | A |
6151522 | Alfano et al. | Nov 2000 | A |
6159445 | Klaveness et al. | Dec 2000 | A |
6160826 | Swanson et al. | Dec 2000 | A |
6161031 | Hochmann et al. | Dec 2000 | A |
6166373 | Mao | Dec 2000 | A |
6174291 | McMahon et al. | Jan 2001 | B1 |
6175669 | Colston et al. | Jan 2001 | B1 |
6185271 | Kinsinger | Feb 2001 | B1 |
6191862 | Swanson et al. | Feb 2001 | B1 |
6193676 | Winston et al. | Feb 2001 | B1 |
6198956 | Dunne | Mar 2001 | B1 |
6201989 | Whitehead et al. | Mar 2001 | B1 |
6208415 | De Boer et al. | Mar 2001 | B1 |
6208887 | Clarke | Mar 2001 | B1 |
6245026 | Campbell et al. | Jun 2001 | B1 |
6249349 | Lauer | Jun 2001 | B1 |
6249381 | Suganuma | Jun 2001 | B1 |
6249630 | Stock et al. | Jun 2001 | B1 |
6263234 | Engelhardt et al. | Jul 2001 | B1 |
6264610 | Zhu | Jul 2001 | B1 |
6272376 | Marcu et al. | Aug 2001 | B1 |
6274871 | Dukor et al. | Aug 2001 | B1 |
6282011 | Tearney et al. | Aug 2001 | B1 |
6297018 | French et al. | Oct 2001 | B1 |
6301048 | Cao et al. | Oct 2001 | B1 |
6308092 | Hoyns | Oct 2001 | B1 |
6324419 | Guzelsu et al. | Nov 2001 | B1 |
6341036 | Tearney et al. | Jan 2002 | B1 |
6353693 | Kano et al. | Mar 2002 | B1 |
6359692 | Groot | Mar 2002 | B1 |
6374128 | Toida et al. | Apr 2002 | B1 |
6377349 | Fercher | Apr 2002 | B1 |
6384915 | Everett et al. | May 2002 | B1 |
6393312 | Hoyns | May 2002 | B1 |
6394964 | Sievert, Jr. et al. | May 2002 | B1 |
6396941 | Bacus et al. | May 2002 | B1 |
6421164 | Tearney et al. | Jul 2002 | B2 |
6437867 | Zeylikovich et al. | Aug 2002 | B2 |
6441892 | Xiao et al. | Aug 2002 | B2 |
6441959 | Yang et al. | Aug 2002 | B1 |
6445485 | Frigo et al. | Sep 2002 | B1 |
6445939 | Swanson et al. | Sep 2002 | B1 |
6445944 | Ostrovsky | Sep 2002 | B1 |
6459487 | Chen et al. | Oct 2002 | B1 |
6463313 | Winston et al. | Oct 2002 | B1 |
6469846 | Ebizuka et al. | Oct 2002 | B2 |
6475159 | Casscells et al. | Nov 2002 | B1 |
6475210 | Phelps et al. | Nov 2002 | B1 |
6477403 | Eguchi et al. | Nov 2002 | B1 |
6485413 | Boppart et al. | Nov 2002 | B1 |
6485482 | Belef | Nov 2002 | B1 |
6501551 | Tearney et al. | Dec 2002 | B1 |
6501878 | Hughes et al. | Dec 2002 | B2 |
6516014 | Sellin et al. | Feb 2003 | B1 |
6517532 | Altshuler et al. | Feb 2003 | B1 |
6538817 | Farmer et al. | Mar 2003 | B1 |
6540391 | Lanzetta et al. | Apr 2003 | B2 |
6549801 | Chen et al. | Apr 2003 | B1 |
6552796 | Magnin et al. | Apr 2003 | B2 |
6556305 | Aziz et al. | Apr 2003 | B1 |
6556853 | Cabib et al. | Apr 2003 | B1 |
6558324 | Von Behren et al. | May 2003 | B1 |
6564087 | Pitris et al. | May 2003 | B1 |
6564089 | Izatt et al. | May 2003 | B2 |
6567585 | Harris | May 2003 | B2 |
6593101 | Richards-Kortum et al. | Jul 2003 | B2 |
6611833 | Johnson et al. | Aug 2003 | B1 |
6615071 | Casscells, III et al. | Sep 2003 | B1 |
6622732 | Constantz | Sep 2003 | B2 |
6654127 | Everett et al. | Nov 2003 | B2 |
6657730 | Pfau et al. | Dec 2003 | B2 |
6658278 | Gruhl | Dec 2003 | B2 |
6680780 | Fee | Jan 2004 | B1 |
6685885 | Nolte et al. | Feb 2004 | B2 |
6687007 | Meigs | Feb 2004 | B1 |
6687010 | Horii et al. | Feb 2004 | B1 |
6687036 | Riza | Feb 2004 | B2 |
6692430 | Adler | Feb 2004 | B2 |
6701181 | Tang et al. | Mar 2004 | B2 |
6721094 | Sinclair et al. | Apr 2004 | B1 |
6738144 | Dogariu et al. | May 2004 | B1 |
6741355 | Drabarek | May 2004 | B2 |
6757467 | Rogers | Jun 2004 | B1 |
6790175 | Furusawa et al. | Sep 2004 | B1 |
6806963 | Wälti et al. | Oct 2004 | B1 |
6816743 | Moreno et al. | Nov 2004 | B2 |
6831781 | Tearney et al. | Dec 2004 | B2 |
6839496 | Mills et al. | Jan 2005 | B1 |
6882432 | Deck | Apr 2005 | B2 |
6900899 | Nevis | May 2005 | B2 |
6903820 | Wang | Jun 2005 | B2 |
6909105 | Heintzmann et al. | Jun 2005 | B1 |
6949072 | Furnish et al. | Sep 2005 | B2 |
6961123 | Wang et al. | Nov 2005 | B1 |
6980299 | de Boer | Dec 2005 | B1 |
6996549 | Zhang et al. | Feb 2006 | B2 |
7006231 | Ostrovsky et al. | Feb 2006 | B2 |
7006232 | Rollins et al. | Feb 2006 | B2 |
7019838 | Izatt et al. | Mar 2006 | B2 |
7027633 | Foran et al. | Apr 2006 | B2 |
7061622 | Rollins et al. | Jun 2006 | B2 |
7072047 | Westphal et al. | Jul 2006 | B2 |
7075658 | Izatt et al. | Jul 2006 | B2 |
7099358 | Chong et al. | Aug 2006 | B1 |
7113288 | Fercher | Sep 2006 | B2 |
7113625 | Watson et al. | Sep 2006 | B2 |
7130320 | Tobiason et al. | Oct 2006 | B2 |
7139598 | Hull et al. | Nov 2006 | B2 |
7142835 | Paulus | Nov 2006 | B2 |
7148970 | De Boer | Dec 2006 | B2 |
7177027 | Hirasawa et al. | Feb 2007 | B2 |
7190464 | Alphonse | Mar 2007 | B2 |
7230708 | Lapotko et al. | Jun 2007 | B2 |
7231243 | Tearney et al. | Jun 2007 | B2 |
7236637 | Sirohey et al. | Jun 2007 | B2 |
7242480 | Alphonse | Jul 2007 | B2 |
7267494 | Deng et al. | Sep 2007 | B2 |
7272252 | De La Torre-Bueno et al. | Sep 2007 | B2 |
7304798 | Izumi et al. | Dec 2007 | B2 |
7330270 | O'Hara et al. | Feb 2008 | B2 |
7336366 | Choma et al. | Feb 2008 | B2 |
7342659 | Horn et al. | Mar 2008 | B2 |
7355716 | De Boer et al. | Apr 2008 | B2 |
7355721 | Quadling et al. | Apr 2008 | B2 |
7359062 | Chen et al. | Apr 2008 | B2 |
7366376 | Shishkov et al. | Apr 2008 | B2 |
7382809 | Chong et al. | Jun 2008 | B2 |
7391520 | Zhou et al. | Jun 2008 | B2 |
7458683 | Chernyak et al. | Dec 2008 | B2 |
7530948 | Seibel et al. | May 2009 | B2 |
7539530 | Caplan et al. | May 2009 | B2 |
7609391 | Betzig | Oct 2009 | B2 |
7630083 | de Boer et al. | Dec 2009 | B2 |
7643152 | de Boer et al. | Jan 2010 | B2 |
7643153 | de Boer et al. | Jan 2010 | B2 |
7646905 | Guittet et al. | Jan 2010 | B2 |
7649160 | Colomb et al. | Jan 2010 | B2 |
7664300 | Lange et al. | Feb 2010 | B2 |
7733497 | Yun et al. | Jun 2010 | B2 |
7782464 | Mujat et al. | Aug 2010 | B2 |
7805034 | Kato et al. | Sep 2010 | B2 |
20010036002 | Tearney et al. | Nov 2001 | A1 |
20010047137 | Moreno et al. | Nov 2001 | A1 |
20020016533 | Marchitto et al. | Feb 2002 | A1 |
20020024015 | Hoffmann et al. | Feb 2002 | A1 |
20020048025 | Takaoka | Apr 2002 | A1 |
20020048026 | Isshiki et al. | Apr 2002 | A1 |
20020052547 | Toida | May 2002 | A1 |
20020057431 | Fateley et al. | May 2002 | A1 |
20020064341 | Fauver et al. | May 2002 | A1 |
20020076152 | Hughes et al. | Jun 2002 | A1 |
20020085209 | Mittleman et al. | Jul 2002 | A1 |
20020086347 | Johnson et al. | Jul 2002 | A1 |
20020091322 | Chaiken et al. | Jul 2002 | A1 |
20020093662 | Chen et al. | Jul 2002 | A1 |
20020109851 | Deck | Aug 2002 | A1 |
20020122182 | Everett et al. | Sep 2002 | A1 |
20020122246 | Tearney et al. | Sep 2002 | A1 |
20020140942 | Fee et al. | Oct 2002 | A1 |
20020158211 | Gillispie | Oct 2002 | A1 |
20020161357 | Anderson et al. | Oct 2002 | A1 |
20020163622 | Magnin et al. | Nov 2002 | A1 |
20020168158 | Furusawa et al. | Nov 2002 | A1 |
20020172485 | Keaton et al. | Nov 2002 | A1 |
20020183623 | Tang et al. | Dec 2002 | A1 |
20020188204 | McNamara et al. | Dec 2002 | A1 |
20020196446 | Roth et al. | Dec 2002 | A1 |
20020198457 | Tearney et al. | Dec 2002 | A1 |
20030001071 | Mandella et al. | Jan 2003 | A1 |
20030013973 | Georgakoudi et al. | Jan 2003 | A1 |
20030023153 | Izatt et al. | Jan 2003 | A1 |
20030026735 | Nolte et al. | Feb 2003 | A1 |
20030028114 | Casscells, III et al. | Feb 2003 | A1 |
20030030816 | Eom et al. | Feb 2003 | A1 |
20030043381 | Fercher | Mar 2003 | A1 |
20030053673 | Dewaele et al. | Mar 2003 | A1 |
20030067607 | Wolleschensky et al. | Apr 2003 | A1 |
20030082105 | Fischman et al. | May 2003 | A1 |
20030097048 | Ryan et al. | May 2003 | A1 |
20030108911 | Klimant et al. | Jun 2003 | A1 |
20030120137 | Pawluczyk et al. | Jun 2003 | A1 |
20030135101 | Webler | Jul 2003 | A1 |
20030137669 | Rollins et al. | Jul 2003 | A1 |
20030164952 | Deichmann et al. | Sep 2003 | A1 |
20030165263 | Hamer et al. | Sep 2003 | A1 |
20030171691 | Casscells, III et al. | Sep 2003 | A1 |
20030174339 | Feldchtein et al. | Sep 2003 | A1 |
20030199769 | Podoleanu et al. | Oct 2003 | A1 |
20030216719 | Debenedictics et al. | Nov 2003 | A1 |
20030220749 | Chen et al. | Nov 2003 | A1 |
20030236443 | Cespedes et al. | Dec 2003 | A1 |
20040002650 | Mandrusov et al. | Jan 2004 | A1 |
20040039298 | Abreu | Feb 2004 | A1 |
20040054268 | Esenaliev et al. | Mar 2004 | A1 |
20040072200 | Rigler et al. | Apr 2004 | A1 |
20040075841 | Van Neste et al. | Apr 2004 | A1 |
20040076940 | Alexander et al. | Apr 2004 | A1 |
20040077949 | Blofgett et al. | Apr 2004 | A1 |
20040085540 | Lapotko et al. | May 2004 | A1 |
20040086245 | Farroni et al. | May 2004 | A1 |
20040100631 | Bashkansky et al. | May 2004 | A1 |
20040100681 | Bjarklev et al. | May 2004 | A1 |
20040110206 | Wong et al. | Jun 2004 | A1 |
20040126048 | Dave et al. | Jul 2004 | A1 |
20040126120 | Cohen et al. | Jul 2004 | A1 |
20040133191 | Momiuchi et al. | Jul 2004 | A1 |
20040150829 | Koch et al. | Aug 2004 | A1 |
20040150830 | Chan | Aug 2004 | A1 |
20040152989 | Puttappa et al. | Aug 2004 | A1 |
20040165184 | Mizuno | Aug 2004 | A1 |
20040166593 | Nolte et al. | Aug 2004 | A1 |
20040189999 | De Groot et al. | Sep 2004 | A1 |
20040212808 | Okawa et al. | Oct 2004 | A1 |
20040239938 | Izatt | Dec 2004 | A1 |
20040246490 | Wang | Dec 2004 | A1 |
20040246583 | Mueller et al. | Dec 2004 | A1 |
20040254474 | Seibel et al. | Dec 2004 | A1 |
20040263843 | Knopp et al. | Dec 2004 | A1 |
20050004453 | Tearney et al. | Jan 2005 | A1 |
20050018133 | Huang et al. | Jan 2005 | A1 |
20050018201 | De Boer | Jan 2005 | A1 |
20050035295 | Bouma et al. | Feb 2005 | A1 |
20050036150 | Izatt et al. | Feb 2005 | A1 |
20050046837 | Izumi et al. | Mar 2005 | A1 |
20050057680 | Agan | Mar 2005 | A1 |
20050057756 | Fang-Yen et al. | Mar 2005 | A1 |
20050059894 | Zeng et al. | Mar 2005 | A1 |
20050065421 | Burckhardt et al. | Mar 2005 | A1 |
20050075547 | Wang | Apr 2005 | A1 |
20050083534 | Riza et al. | Apr 2005 | A1 |
20050119567 | Choi et al. | Jun 2005 | A1 |
20050128488 | Milen et al. | Jun 2005 | A1 |
20050165303 | Kleen et al. | Jul 2005 | A1 |
20050171438 | Chen et al. | Aug 2005 | A1 |
20050190372 | Dogariu et al. | Sep 2005 | A1 |
20050254061 | Alphonse et al. | Nov 2005 | A1 |
20060033923 | Hirasawa et al. | Feb 2006 | A1 |
20060093276 | Bouma et al. | May 2006 | A1 |
20060103850 | Alphonse et al. | May 2006 | A1 |
20060146339 | Fujita et al. | Jul 2006 | A1 |
20060155193 | Leonardi et al. | Jul 2006 | A1 |
20060164639 | Horn et al. | Jul 2006 | A1 |
20060171503 | O'Hara et al. | Aug 2006 | A1 |
20060184048 | Saadat et al. | Aug 2006 | A1 |
20060193352 | Chong et al. | Aug 2006 | A1 |
20060244973 | Yun et al. | Nov 2006 | A1 |
20060279742 | Tearney | Dec 2006 | A1 |
20070019208 | Toida et al. | Jan 2007 | A1 |
20070038040 | Cense et al. | Feb 2007 | A1 |
20070070496 | Gweon et al. | Mar 2007 | A1 |
20070076217 | Baker et al. | Apr 2007 | A1 |
20070086013 | De Lega et al. | Apr 2007 | A1 |
20070086017 | Buckland et al. | Apr 2007 | A1 |
20070091317 | Freischlad et al. | Apr 2007 | A1 |
20070133002 | Wax et al. | Jun 2007 | A1 |
20070188855 | Shishkov et al. | Aug 2007 | A1 |
20070223006 | Tearney et al. | Sep 2007 | A1 |
20070236700 | Yun et al. | Oct 2007 | A1 |
20070258094 | Izatt et al. | Nov 2007 | A1 |
20070291277 | Everett et al. | Dec 2007 | A1 |
20080002197 | Sun et al. | Jan 2008 | A1 |
20080007734 | Park et al. | Jan 2008 | A1 |
20080049220 | Izzia et al. | Feb 2008 | A1 |
20080094613 | de Boer et al. | Apr 2008 | A1 |
20080094637 | de Boer et al. | Apr 2008 | A1 |
20080097225 | Tearney et al. | Apr 2008 | A1 |
20080097709 | de Boer et al. | Apr 2008 | A1 |
20080100837 | de Boer et al. | May 2008 | A1 |
20080152353 | de Boer et al. | Jun 2008 | A1 |
20080154090 | Hashimshony | Jun 2008 | A1 |
20080204762 | Izatt et al. | Aug 2008 | A1 |
20080228086 | Ilegbusi | Sep 2008 | A1 |
20080265130 | Colomb et al. | Oct 2008 | A1 |
20080308730 | Vizi et al. | Dec 2008 | A1 |
20090005691 | Huang | Jan 2009 | A1 |
20090011948 | Uniu et al. | Jan 2009 | A1 |
20090196477 | Cense et al. | Aug 2009 | A1 |
20090273777 | Yun et al. | Nov 2009 | A1 |
20090290156 | Popescu et al. | Nov 2009 | A1 |
20100086251 | Xu et al. | Apr 2010 | A1 |
20100094576 | de Boer et al. | Apr 2010 | A1 |
20100150467 | Zhao et al. | Jun 2010 | A1 |
Number | Date | Country |
---|---|---|
1550203 | Dec 2004 | CN |
4105221 | Sep 1991 | DE |
4309056 | Sep 1994 | DE |
19542955 | May 1997 | DE |
10351319 | Jun 2005 | DE |
0110201 | Jun 1984 | EP |
0251062 | Jan 1988 | EP |
0617286 | Feb 1994 | EP |
0590268 | Apr 1994 | EP |
0728440 | Aug 1996 | EP |
0933096 | Aug 1999 | EP |
1324051 | Jul 2003 | EP |
1426799 | Jun 2004 | EP |
2738343 | Aug 1995 | FR |
1257778 | Dec 1971 | GB |
2030313 | Apr 1980 | GB |
2209221 | May 1989 | GB |
2298054 | Aug 1996 | GB |
6073405 | Apr 1985 | JP |
20040056907 | Feb 1992 | JP |
4135550 | May 1992 | JP |
4135551 | May 1992 | JP |
5509417 | Nov 1993 | JP |
2002214127 | Jul 2002 | JP |
20030035659 | Feb 2003 | JP |
2007271761 | Oct 2007 | JP |
7900841 | Oct 1979 | WO |
9201966 | Feb 1992 | WO |
9216865 | Oct 1992 | WO |
9219930 | Nov 1992 | WO |
9303672 | Mar 1993 | WO |
9533971 | Dec 1995 | WO |
9628212 | Sep 1996 | WO |
9732182 | Sep 1997 | WO |
9800057 | Jan 1998 | WO |
9801074 | Jan 1998 | WO |
9814132 | Apr 1998 | WO |
9835203 | Aug 1998 | WO |
9838907 | Sep 1998 | WO |
9846123 | Oct 1998 | WO |
9848838 | Nov 1998 | WO |
9848846 | Nov 1998 | WO |
9905487 | Feb 1999 | WO |
9944089 | Feb 1999 | WO |
9944089 | Sep 1999 | WO |
9957507 | Nov 1999 | WO |
0058766 | Oct 2000 | WO |
0101111 | Jan 2001 | WO |
0108579 | Feb 2001 | WO |
0127679 | Apr 2001 | WO |
0138820 | May 2001 | WO |
0142735 | Jun 2001 | WO |
0236015 | May 2002 | WO |
0237075 | May 2002 | WO |
0238040 | May 2002 | WO |
02053050 | Jul 2002 | WO |
02054027 | Jul 2002 | WO |
02084263 | Oct 2002 | WO |
03020119 | Mar 2003 | WO |
03046495 | Jun 2003 | WO |
03046636 | Jun 2003 | WO |
03052478 | Jun 2003 | WO |
03062802 | Jul 2003 | WO |
03105678 | Dec 2003 | WO |
2004034869 | Apr 2004 | WO |
2004057266 | Jul 2004 | WO |
2004066824 | Aug 2004 | WO |
2004088361 | Oct 2004 | WO |
2004105598 | Dec 2004 | WO |
2005000115 | Jan 2005 | WO |
2005047813 | May 2005 | WO |
2005054780 | Jun 2005 | WO |
2005082225 | Sep 2005 | WO |
2006004743 | Jan 2006 | WO |
2006014392 | Feb 2006 | WO |
2006038876 | Apr 2006 | WO |
2006039091 | Apr 2006 | WO |
2006059109 | Jun 2006 | WO |
2006124860 | Nov 2006 | WO |
2006130797 | Dec 2006 | WO |
2007028531 | Mar 2007 | WO |
2007038787 | Apr 2007 | WO |
2007083138 | Jul 2007 | WO |
2007084995 | Jul 2007 | WO |
Number | Date | Country | |
---|---|---|---|
20090036770 A1 | Feb 2009 | US |
Number | Date | Country | |
---|---|---|---|
60287899 | May 2001 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10137749 | May 2002 | US |
Child | 12188623 | US |